{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:05Z","timestamp":1772166185159,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Women are born with a limited number of eggs, which decline over time. Premature ovarian insufficiency (POI) occurs when this decline happens before age 40, causing infertility. Bone marrow (BM) stem cells may help restore ovarian function, as some women conceive after BM transplants. Studies suggest that mobilizing stem cells with Granulocyte Colony-Stimulating Factor (G-CSF) can improve ovarian response in women with diminished ovarian reserve, possibly without needing ovarian infusion. Our study aimed to evaluate if G-CSF injections alone could improve ovarian function in women with POI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a pilot, non-randomized, open-label clinical trial including 11 women aged 25\u201340 years with clinical POI and menopausal symptoms, defined by elevated follicle-stimulating hormone (FSH) on two occasions, low anti-M\u00fcllerian hormone (AMH), and reduced antral follicle count (AFC). Participants received up to three rounds of subcutaneous G-CSF administered daily for four days per month over 60 days. Ovarian reserve markers (FSH, AMH, AFC), menstruation resumption, and menopausal symptoms were assessed at baseline and multiple follow-up points over 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of participants was 34.1\u2009\u00b1\u20095.2 years (BMI 23.96\u2009\u00b1\u20094.0\u00a0kg\/m\u00b2). GCS-F injections resulted in significant increases in white blood cells and mild elevation of liver enzymes which returned to baseline within one month. By four months, significant improvements in menopausal symptoms were reported. Exploratory analyses did not identify consistent correlations between clinical response and baseline characteristics. Mean FSH decreased from 54.3\u2009\u00b1\u200924.6 IU\/L at baseline to 29.0\u2009\u00b1\u20098.1 IU\/L at six months (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008). AMH and AFC rose modestly (0.21\u2009\u00b1\u20090.15 to 0.49\u2009\u00b1\u20091.13 pmol\/L; 1.09\u2009\u00b1\u20091.0 to 2.18\u2009\u00b1\u20092.60) but did not reach statistical significance. Menstruation resumed in 7 of 11 women (63.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031). One participant showed marked response including retrieval of three mature oocytes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>G-CSF injections were associated with menstrual resumption and symptom relief in most women with POI, suggesting biological activity. Although improvements in ovarian reserve markers were modest and disappointing in terms of the potential for assisted reproduction, these findings may support further evaluation of G-CSF in larger, controlled trials to clarify its clinical benefit and therapeutic potential.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      NCT06117982.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06117982?cond=The%20Impact%20of%20Granulocyte%20Colony%20Stimulating%20Factor%20on%20Premature%20Ovarian%20Insufficiency&amp;rank=1\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT06117982?cond=The%20Impact%20of%20Granulocyte%20Colony%20Stimulating%20Factor%20on%20Premature%20Ovarian%20Insufficiency&amp;rank=1<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12958-025-01510-z","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T02:06:15Z","timestamp":1767751575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Granulocyte colony-stimulating factor treatment in women with premature ovarian insufficiency: a pilot clinical study of biological activity and menstrual resumption"],"prefix":"10.1186","volume":"24","author":[{"given":"Yasaman","family":"Sadeghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Deda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Albar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Casper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1510_CR1","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/humrep\/dem408","volume":"23","author":"KR Hansen","year":"2008","unstructured":"Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23:699\u2013708.","journal-title":"Hum Reprod"},{"key":"1510_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.34172\/apb.2024.059","volume":"14","author":"Y Yahyavi","year":"2024","unstructured":"Yahyavi Y, Kheradi N, Karimi A, Ebrahimi-Kalan A, Ramezani F, Yousefi S, et al. Novel advances in Cell-Free therapy for premature ovarian failure (POF): A comprehensive review. Adv Pharm Bull. 2024;14:543\u201357.","journal-title":"Adv Pharm Bull"},{"key":"1510_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/humrep\/dew027","volume":"31","author":"L Webber","year":"2016","unstructured":"The ESHRE Guideline Group on POI, Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. Vermeulen, ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31:926\u201337.","journal-title":"Hum Reprod"},{"issue":"2","key":"1510_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0015-0282(01)02987-9","volume":"77","author":"A Hershlag","year":"2002","unstructured":"Hershlag A, Schuster MW. Return of fertility after autologous stem cell transplantation. Fertil Steril. 2002;77(2):419\u201321.","journal-title":"Fertil Steril"},{"key":"1510_CR5","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1182\/blood.V87.7.3045.bloodjournal8773045","volume":"87","author":"A Merloni","year":"1996","unstructured":"Merloni A, Hawley J, Levy WC, Gooley T, Cd B, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high- dose Busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045\u201352.","journal-title":"Blood"},{"key":"1510_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0140-6736(01)05482-4","volume":"28358","author":"N Salooja","year":"2001","unstructured":"Salooja N, Szydlo R, Soci\u00e9 G, Rio B, Chatterjee RM, Ljungman P, et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey. Lancet. 2001;28358:271\u20136.","journal-title":"Lancet"},{"key":"1510_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/jhrs.JHRS_130_19","volume":"13","author":"S Tandulwadkar","year":"2020","unstructured":"Tandulwadkar S, Karthick MS. Combined use of autologous bone Marrow-derived stem cells and Platelet-rich plasma for ovarian rejuvenation in poor responders. J Hum Reprod Sci. 2020;13:184\u201390.","journal-title":"J Hum Reprod Sci"},{"issue":"1","key":"1510_CR8","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1016\/j.ajog.2021.01.023","volume":"225","author":"A Buigues","year":"2021","unstructured":"Buigues A, Marchante M, de Miguel-G\u00f3mez L, Martinez J, Cervell\u00f3 I, Pellicer A, et al. Stem cell-secreted factor therapy regenerates the ovarian niche and rescues follicles. Am J Obstet Gynecol. 2021;225(1):e651\u201314.","journal-title":"Am J Obstet Gynecol"},{"key":"1510_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.fertnstert.2018.04.025","volume":"110","author":"S Herraiz","year":"2018","unstructured":"Herraiz S, Romeu M, Buigues A, Mart\u00ednez S, D\u00edaz-Garc\u00eda C, G\u00f3mez-Segu\u00ed I, et al. Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders. Fertil Steril. 2018;110:496\u2013e5051.","journal-title":"Fertil Steril"},{"key":"1510_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/GCO.0000000000000531","volume":"31","author":"S Herraiz","year":"2019","unstructured":"Herraiz S, Pellicer N, Romeu M, Pellicer A. Treatment potential of bone marrow-derived stem cells in women with diminished ovarian reserves and premature ovarian failure. Curr Opin Obstet Gynecol. 2019;31:156\u201362.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1510_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/biomedicines6030093","volume":"6","author":"A El Andaloussi","year":"2018","unstructured":"El Andaloussi A, Igboeli P, Amer A, Al-Hendy A. Intravenous infusion of nucleated peripheral blood cells restores fertility in mice with Chemotherapy-Induced premature ovarian failure. Biomedicines. 2018;6:93.","journal-title":"Biomedicines"},{"issue":"1","key":"1510_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5530\/ami.2016.1.7","volume":"3","author":"M Edessy","year":"2015","unstructured":"Edessy M, Hosni HN, Shady YA, Waf Y, Bakr S, Kamel MM. Autologous stem cells therapy, the first baby of idiopathic premature ovarian failure. Acta Med Int. 2015;3(1):19.","journal-title":"Acta Med Int"},{"issue":"2","key":"1510_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/jhrs.JHRS_57_18","volume":"11","author":"S Gupta","year":"2018","unstructured":"Gupta S, Lodha P, Karthick MS, Tandulwadkar SR. Role of autologous bone Marrow-Derived stem cell therapy for follicular recruitment in premature ovarian insufficiency: review of literature and a case report of world\u2019s first baby with ovarian autologous stem cell therapy in a perimenopausal woman of age 45 year. J Hum Reprod Sci. 2018;11(2):125\u201330.","journal-title":"J Hum Reprod Sci"},{"key":"1510_CR14","doi-asserted-by":"publisher","first-page":"17474","DOI":"10.1073\/pnas.1312830110","volume":"110","author":"K Kawamura","year":"2013","unstructured":"Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, Ho CH, Kawamura N, Tamura M, Hashimoto S, Sugishita Y, Morimoto Y, Hosoi Y, Yoshioka N, Ishizuka B, Hsueh AJ. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A. 2013;110:17474\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1510_CR15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s10815-022-02579-w","volume":"39","author":"M M\u00e9ndez","year":"2022","unstructured":"M\u00e9ndez M, Fabregues F, Ferreri J, Calafell JM, Villarino A, Otero J, Farre R, Carmona F. Biomechanical characteristics of the ovarian cortex in POI patients and functional outcomes after drug-free IVA. J Assist Reprod Genet. 2022;39(8):1759\u201367.","journal-title":"J Assist Reprod Genet"},{"issue":"11","key":"1510_CR16","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.18632\/aging.103403","volume":"12","author":"Y Cakiroglu","year":"2020","unstructured":"Cakiroglu Y, Saltik A, Yuceturk A, Karaosmanoglu O, Kopuk SY, Scott RT, et al. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging. 2020;12(11):10211\u201322.","journal-title":"Aging"},{"issue":"1","key":"1510_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s40001-025-02854-3","volume":"30","author":"S Sadeghpour","year":"2025","unstructured":"Sadeghpour S, Maleki F, Hajizadeh-Sharafabad F, Ghasemnejad-Berenji H. Evaluation of intraovarian injection of platelet-rich plasma for enhanced ovarian function and reproductive success in women with POI and POR: a systematic review and meta-analysis. Eur J Med Res. 2025;30(1):610.","journal-title":"Eur J Med Res"},{"issue":"1","key":"1510_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12884-024-06251-2","volume":"24","author":"AM Maged","year":"2024","unstructured":"Maged AM, Mohsen RA, Salah N, Ragab WS. The value of intraovarian autologous platelet rich plasma in women with poor ovarian reserve or ovarian insufficiency: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2024;24(1):85.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"6","key":"1510_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1097\/01.scs.0000186454.07097.bf","volume":"16","author":"WS Pietrzak","year":"2005","unstructured":"Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16(6):1043\u201354.","journal-title":"J Craniofac Surg"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01510-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01510-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01510-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:37:29Z","timestamp":1770201449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12958-025-01510-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1510"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01510-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7917847\/v1","asserted-by":"object"}]},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by Veritas Independent Review Board (2023-3224-14057-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}